Goldman Sachs Group Inc. reduced its position in shares of Cross Country Healthcare, Inc. (NASDAQ:CCRN) by 24.5% during the first quarter, Holdings Channel reports. The firm owned 90,427 shares of the business services provider’s stock after selling 29,320 shares during the period. Goldman Sachs Group Inc.’s holdings in Cross Country Healthcare were worth $1,299,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. LS Investment Advisors LLC boosted its stake in shares of Cross Country Healthcare by 484.5% in the first quarter. LS Investment Advisors LLC now owns 7,184 shares of the business services provider’s stock worth $103,000 after buying an additional 5,955 shares during the last quarter. Globeflex Capital L P purchased a new stake in shares of Cross Country Healthcare during the first quarter worth $104,000. Mason Street Advisors LLC boosted its stake in shares of Cross Country Healthcare by 6.9% in the first quarter. Mason Street Advisors LLC now owns 7,713 shares of the business services provider’s stock worth $111,000 after buying an additional 499 shares during the last quarter. Campbell & CO Investment Adviser LLC purchased a new stake in shares of Cross Country Healthcare during the first quarter worth $157,000. Finally, Sapphire Star Partners LP purchased a new stake in shares of Cross Country Healthcare during the first quarter worth $161,000. Hedge funds and other institutional investors own 90.00% of the company’s stock.

Shares of Cross Country Healthcare, Inc. (CCRN) traded down 0.24% during midday trading on Thursday, reaching $12.57. 40,644 shares of the company’s stock traded hands. Cross Country Healthcare, Inc. has a 52-week low of $10.54 and a 52-week high of $16.38. The stock has a market cap of $458.73 million, a price-to-earnings ratio of 46.38 and a beta of 0.83. The stock has a 50 day moving average of $12.36 and a 200-day moving average of $13.40.

Cross Country Healthcare (NASDAQ:CCRN) last issued its quarterly earnings results on Wednesday, August 2nd. The business services provider reported $0.16 EPS for the quarter, topping the Zacks’ consensus estimate of $0.09 by $0.07. Cross Country Healthcare had a return on equity of 12.78% and a net margin of 1.06%. The company had revenue of $209.31 million for the quarter, compared to analysts’ expectations of $209.92 million. During the same quarter last year, the business earned $0.16 earnings per share. Cross Country Healthcare’s revenue was up 4.9% on a year-over-year basis. On average, equities research analysts expect that Cross Country Healthcare, Inc. will post $0.61 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This piece was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.watchlistnews.com/goldman-sachs-group-inc-has-1-30-million-position-in-cross-country-healthcare-inc-ccrn/1470999.html.

A number of analysts have recently weighed in on CCRN shares. Benchmark Co. restated a “buy” rating and issued a $17.00 price objective (down from $18.00) on shares of Cross Country Healthcare in a research note on Wednesday. Zacks Investment Research upgraded shares of Cross Country Healthcare from a “hold” rating to a “buy” rating and set a $13.00 price objective for the company in a research note on Monday. UBS AG reaffirmed a “buy” rating and set a $15.00 target price (down previously from $16.50) on shares of Cross Country Healthcare in a research report on Wednesday, June 14th. Finally, BMO Capital Markets dropped their target price on shares of Cross Country Healthcare from $18.00 to $15.00 and set an “outperform” rating on the stock in a research report on Friday, May 5th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and five have assigned a buy rating to the company’s stock. Cross Country Healthcare presently has a consensus rating of “Buy” and a consensus price target of $15.64.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Want to see what other hedge funds are holding CCRN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cross Country Healthcare, Inc. (NASDAQ:CCRN).

Institutional Ownership by Quarter for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.